BMJ Review Time

BMJ was down from 55.0 in 2023 to 42.7 in 2024 as pandemic-era citation inflation continued to unwind. The practical read is not that the journal weakened. It is that BMJ has returned closer to its true public-health and primary-care baseline after two abnormal COVID years.

BMJ publishes reviewer names alongside accepted papers. Reviewers know their identity will be public, which changes the review dynamic:

• Reviews tend to be more constructive and less adversarial
• Ad hominem or dismissive comments are rare (reviewers sign their name)
• The review process feels more accountable
• Some reviewers decline to review because of the transparency requirement

For authors, open review means the feedback you receive is usually more carefully considered. It also means reviewers are less likely to make unreasonable demands, because their requests become part of the public record.

BMJ research articles are published open access without an author-facing article processing charge. This is funded by BMJ's other revenue streams. It removes the financial barrier that makes some journals inaccessible to researchers without grants.

BMJ's editorial criteria emphasize population health impact alongside clinical significance. A paper doesn't just need to show that a treatment works. It needs to show that the finding matters at a population level. Papers about rare diseases or highly specialized interventions may be better suited to specialty journals.

Fast desk rejection (1-2 weeks): The clinical importance isn't strong enough or the population health relevance is unclear. Common outcome.

Desk rejection with detailed feedback (2-3 weeks): BMJ sometimes provides editorial reasoning for desk rejections, which is more generous than many journals. Use this feedback.

Review taking 6+ weeks: Normal. Open review means BMJ needs to find reviewers willing to have their names published. This can take longer than anonymous review.

Revision with statistical requests: Common. BMJ's statistical advisors often identify issues that clinical peer reviewers miss.

BMJ timing only helps if it changes how you prepare the paper. A long review cycle is often a signal that the manuscript is carrying real clinical and statistical scrutiny, not that the journal is disorganized. The pages below are the ones that usually matter next:

• BMJ submission process
• BMJ under review
• BMJ pre-submission checklist

BMJ's timeline is best read as a triage model with a long middle, not as a uniformly slow journal. The fast desk decision is the journal deciding whether the paper has enough public-health importance to justify sending named reviewers and statistical advisers into the file. Once a paper clears that filter, the open-review model and methodological scrutiny often make the process feel slower because the journal is trying to produce criticism it can stand behind publicly.

For authors, that means the most useful preparation step is not impatience management. It is making the abstract and methods impossible to misread on population relevance, study design, and reporting completeness before submission.

In our pre-submission review work on BMJ-targeted manuscripts, the biggest timing mistakes usually happen before the paper ever reaches named reviewers. The methods can be strong and the result can be useful, but the manuscript still has to read like a BMJ paper rather than a specialty paper with a general-medicine wrapper.

The action point is implied instead of named. BMJ editors move faster when the conclusion makes a concrete practice, policy, or public-health implication visible immediately. If the paper stops at documenting a problem and expects the reader to infer the action, the desk stage gets harder.

The audience is broader in theory than in practice. We see many papers that are excellent for one specialty journal but too narrow for the flagship. BMJ editors specifically screen whether a general physician, health-system reader, or public-health decision-maker can use the paper without specialist translation.

Reporting transparency is almost good enough. Open review changes the standard. Weaknesses in methods reporting, limitations framing, or protocol transparency are more exposed here because reviewers know their names will sit next to the file if the paper is accepted. Our review of BMJ submissions repeatedly finds that papers which look fine at ordinary journals still lose momentum here if the transparency layer feels one draft behind the science.

We see the cleanest BMJ outcomes when the abstract states the practical consequence in the same sentence as the result and the methods section leaves little room for reviewer suspicion. That combination lowers friction at both triage and open review.

Published timelines are medians that can mask real variation. Desk rejections (often 1-3 weeks) skew the median down, making the number shorter than what reviewed papers actually experience. Seasonal effects (December submissions sit longer, September backlogs) and field-specific reviewer availability also affect your specific wait time. The timeline does not include acceptance-to-publication time.

A BMJ desk-rejection risk check scores fit against the journal's editorial bar.